
yl23455永利汇总整理了12月生物医药行业聚会供参考交流。。同时,,我们将妄想加入海内外5场聚会:
- “SLAS-ELRIG Networking Event”
- “Genesis 2023”
- "Mediclon Boston Opening"
- “ASH 2023”
- “2023深圳湾实验室转化医学岑岭论坛”

marketing@medicilon.com.cn
媒体与会务请联系微信或邮箱

Ready to Meet Medicilon at SLAS-ELRIG Networking Event?
Revolutionary Adhesion: Unveiling the Power of Molecular Glues in Medicine, Science and Beyond!
We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.
Proteolysis targeting chimeras (PROTACs) offer a fast and reversible chemical knock-down approach to control protein function. PROTAC technology takes advantage of a moiety of targeted protein and a moiety of recognizing E3 ubiquitin ligase and produces a hybrid molecule to specifically knock down a targeted protein.
Medicilon provides PROTAC drug discovery, CMC research (API + formulation), pharmacodynamics research, PK study, safety evaluation and other services. Medicilon’s PROTAC drug discovery technology platform covers the currently popular target protein ligands. We have established a linker system with an extensive collection of bifunctional linkers. Together with our expanding E3 ubiquitin ligase binder library, we can efficiently synthesize a substantial amount of highly active PROTAC bispecific small molecules, which would have the potential to significantly facilitate the drug discovery and development process. As of the end of June 2023, Medicilon has successfully assisted in the clinical approval of 5 PROTAC drugs and has 20+ PROTAC projects under development.
Date: Tuesday 5 December 2023 from 10:00 -18:00
Location: 1 Wimpole Street, London, W1G 0AE

Join Medicilon at Genesis 2023!
Fostering Innovation, Investment, and Deal-making at Genesis 2023.
For over two decades, the annual Genesis conference has brought key Life Science opinion leaders and stakeholders together to debate key trends, instigate deals and generate a vision of the future.
By facilitating critical networking, and sharing the latest insights in the Life Sciences industry, One Nucleus' Genesis 2023 & Genesis Fringe Seminars can help you and your organization along your journey to success. 300 delegates from across the industry attend Genesis, and this year is expected to achieve the same on 5-8 December in Central London. Between the insightful keynote sessions are valuable breaks where you can continue the exciting stimulating discussions, and meet contacts old and new.
Dr. Jing Deng, our VP of Pharmacology, Pharmacodynamics and Biology Department, will give a great presentation titled "New technology platforms in preclinical research" in Genesis Fringe Seminar on December 5th, 2023, 18:00-21:00 pm.

InnoXBio生物医药工业生态圈大会暨首届大湾区细胞基因治疗生长论坛定于2023年12月7-8日,,在广州知识城国际会展中心召开,,大会将约请CGT工业上下游行业专家,,以主题演讲、圆桌讨论、产品展示等形式分享行业效果与前沿动态,,掌握工业生长脉搏,,携手各方,,共筑工业兴!

Celebrate Mediclon Boston Opening!
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D service for pharmaceutical enterprises and scientific research institutions around the world. We are excited to invite you to the Medicilon Boston Site Opening Reception for a great time of lunch, networking, and discussion.
The theme of this event is to share hopes and bright future of biomedicine. With the opening its Boston site, Medicilon is committed to working ever closely with our partners in their pursuit of finding cures for patients in need.
Date: December 9th, 2023 (Saturday)
Time:11:00 am - 2:00 pm
Venue: Medicilon Boston Site (50 Soldiers Field Place, Boston, MA 02135)

We look forward to meeting you at ASH 2023!
With more than 18,000 members from nearly 100 countries, ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. Fostering high-quality, equitable care, transformative research, and innovative education to improve the lives of patients with blood and bone marrow disorders.
Medicilon team are present throughout the conference.
Medicilon translational medicine platform is committed to providing global partners with comprehensive biomarker discovery, target integrated solutions for point-of-care verification, companion diagnostic development, and commercial testing.
We look forward to welcoming you in San Diego!
Date: December 9-12, 2023
Location: San Diego

由深圳市坪山区科技立异局指导,,南方科技大学坪山生物医药研究院和化学化工专业委员会联合主理,,深圳市坪山区小分子新药创联协会、药渡经纬信息科技(北京)有限公司、银星坪山生命康健科技园联合承办,,深圳市坪山区工业资源投资有限公司、贝壳学社、深圳市生命科学与生物手艺协会、深圳市坪山区高条理人才协会、深圳市华先医药科技有限公司、深圳艾欣达伟医药科技有限公司、深圳安乐维生物医药有限公司、深圳格林凯特医药手艺有限公司、化学加联合协办的“2023深圳生物医药工业立异生长岑岭论坛暨化学化工专业委员会年会”,,制订于2023年12月10日在深圳市坪山银星生命康健工业园举行。。

本次聚会以“医药立异加速、转化助力共赢”为主题,,汇聚海内外有实战转化履历的科研院所、立异药企、生物科技公司、投资公司、CXO等生态群体,,助力科研机构医药立异与转化,,致力于打造中国医药立异和转化领域顶尖的行业盛会。。
参会嘉宾迁就“新型科研机构怎样举行转化”“医药资源市场对立异药开发偏向”“立异药源头开发战略”以及“科研机构怎样同药企举行更好的相助”等问题配合思索、分享实践、探寻要领。。

由长三角企业家同盟、浙江省工商业联合会指导,,杭州市滨江区人民政府、长三角数据驱动立异生物医药工业链同盟、中国生物医药工业链立异转化联合体主理,,火石数链、贝达药业、南京生物医药立异转化中心、药咖荟承办的“长三角生物医药工业大会”将于2023年12月14-16日在杭州召开。。
本次大会以“数智时代 医药生涯与立异”为主题,,整合长三角地区IT+BT资源,,交流探讨数字手艺赋能生物医药工业数字化转型新路径与新履历,,推进工业大数据及数字手艺在药物发明、设计、研发、临床研究、质量检测、全链条治理等数字化场景应用立异。。通过数据驱动+工业互联,,把工业数字化治理与药械企业立异生态构建相连系,,以数据流发动营业流,,推动数据要素价值化,,医药营销合规化,,打造效劳天下的工业效劳交流平台,,实现数据驱动全要素生产率和医药工业资源设置效率的提升,,助力长三角数字化生长之路走深走实,,共筑工业新生态。。

生物医药作为中国七大战略性新兴工业之一,,是康健中国建设的主要基础,,也是宁波市重点聚焦的战略性新兴工业。。为深入推进生物医药工业高质量快速生长,,优化全球临床开发和跨境相助,,增进手艺效果推介和供需对接,,“第二届中国?宁波生物医药工业生长大会”暨“第三届新药创业在前湾项目路演&投融资洽谈会”将于2023年12月15-17日在前湾新区宁波杭州湾凯悦旅馆举行。。
聚会将围绕立异药研发、细胞基因疗法、AI与合成生物学、小核酸药物研发、中药现代化等专题举行探讨交流,,深度融合行业资源和工业资源,,配合推进生物医药工业的蓬勃生长。。真挚地约请您拨冗出席本次盛会!

作为中国生物医药四大群集地之一,,京津冀地区已成为我国生物医药工业生长主要集聚地之一,,起源形成了以北京为焦点、天津和河北互补协作的工业协同生长名堂。。其中北京生物医药工业立异优势突出,,起源形成了“一南一北、各具特色”的空间结构。。“南”包括以亦庄和大兴生物医药基地为焦点的高端工业基地,,“北”包括以中关村生命科学园为焦点的研发立异中心。。
其中RNA疗法工业华北论坛将聚焦RNA疗法突破,,关注小核酸药物开发、mRNA新型熏染病疫苗、mRNA新型癌症疫苗等产品的开发,,大会将于12月27日-28日在北京举行,,基于前三届RNA疗法与新型疫苗工业峰会,,本次峰会将吸引凌驾1300人次参会嘉宾。。

marketing@medicilon.com.cn
微信或邮件联系yl23455永利